These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7705665)

  • 1. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival.
    Scarabelli C; Gallo A; Zarrelli A; Visentin C; Campagnutta E
    Gynecol Oncol; 1995 Mar; 56(3):328-37. PubMed ID: 7705665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease.
    Scarabelli C; Gallo A; Visentin MC; Canzonieri V; Carbone A; Zarrelli A
    Int J Gynecol Cancer; 1997 Jan; 7(1):18-26. PubMed ID: 12795800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
    Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
    J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
    Berek JS
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy.
    Spirtos NM; Gross GM; Freddo JL; Ballon SC
    Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer.
    Isonishi S; Niimi S; Sasaki H; Ochiai K; Yasuda M; Tanaka T
    Gynecol Oncol; 2004 Jun; 93(3):647-52. PubMed ID: 15196859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
    Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
    Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
    Chang SJ; Bristow RE; Ryu HS
    Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
    Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
    J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
    Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
    Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
    Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
    Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
    Song N; Gao Y
    Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].
    Takahashi Y; Akiyama M; Hirose M; Yamamoto Y; Tenzaki T; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1095-100. PubMed ID: 8245587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer.
    Yokoyama Y; Sakamoto T; Sato S; Saito Y
    Eur J Gynaecol Oncol; 1999; 20(5-6):361-6. PubMed ID: 10609495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Para-aortic lymphadenectomy below inferior mesenteric artery versus renal vessels in stage IIIC epithelial ovarian cancer: A comparison of surgical outcomes.
    Zhu C; Zhu H; Wang Y; Cui H; Li Y
    Int J Gynaecol Obstet; 2020 Feb; 148(2):192-197. PubMed ID: 31746467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients.
    Onda T; Yoshikawa H; Yasugi T; Mishima M; Nakagawa S; Yamada M; Matsumoto K; Taketani Y
    Cancer; 1998 Oct; 83(8):1555-60. PubMed ID: 9781949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma.
    Ho CM; Chien TY; Shih BY; Huang SH
    Gynecol Oncol; 2003 Mar; 88(3):394-9. PubMed ID: 12648592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.